BLT 0.00% 2.6¢ benitec biopharma limited

CC

  1. 536 Posts.
    lightbulb Created with Sketch. 1
    My thoughts on the conference call-

    Good chance we get a grant from the American Association of OPMD.
    Take OPMD through phase one human trials then find a partner.
    Head & Neck program has lot's of promise in terms of what they learn from the data can be used for other rare cancer targets. (sounds like more Nant/ Benitec partnered programs
    AMD - will likely be shelved.
    HBV-Still being shopped around..
    Instead of a replacement for cliff they are going to contract each program out to consulting firms who have skills for the different programs.
    David Suhy said the silence & replace vector was very well received by all the regulatory agencies they spoke to regarding OPMD.
 
watchlist Created with Sketch. Add BLT (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.